Literature DB >> 16650890

Parameters influencing the stealthiness of colloidal drug delivery systems.

Arnaud Vonarbourg1, Catherine Passirani, Patrick Saulnier, Jean-Pierre Benoit.   

Abstract

Over the last few decades, colloidal drug delivery systems (CDDS) such as nano-structures have been developed in order to improve the efficiency and the specificity of drug action. Their small size permits them to be injected intravenously in order to reach target tissues. However, it is known that they can be rapidly removed from blood circulation by the immune system. CDDS are removed via the complement system and via the cells of the mononuclear phagocyte system (MPS), after their recognition by opsonins and/or receptors present at the cell surface. This recognition is dependent on the physicochemical characteristics of the CDDS. In this study, we will focus on parameters influencing the interactions of opsonins and the macrophage plasma membrane with the surface of CDDS, whereby parameters of the polymer coating become necessary to provide good protection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650890     DOI: 10.1016/j.biomaterials.2006.03.039

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  120 in total

1.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

Review 2.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 3.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

4.  Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy.

Authors:  Sang-Min Lee; Richard W Ahn; Feng Chen; Angela J Fought; Thomas V O'Halloran; Vincent L Cryns; Sonbinh T Nguyen
Journal:  ACS Nano       Date:  2010-09-28       Impact factor: 15.881

5.  Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles.

Authors:  Cherry C Chen; Shashank R Sirsi; Shunichi Homma; Mark A Borden
Journal:  Ultrasound Med Biol       Date:  2012-03       Impact factor: 2.998

6.  Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel.

Authors:  Eun-Hye Lee; Soon-Seok Hong; So Hee Kim; Mi-Kyung Lee; Joon Seok Lim; Soo-Jeong Lim
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

7.  Polymeric micelles of PEG-PE as carriers of all-trans retinoic acid for stability improvement.

Authors:  Angkana Wichit; Anothai Tangsumranjit; Tasana Pitaksuteepong; Neti Waranuch
Journal:  AAPS PharmSciTech       Date:  2012-01-25       Impact factor: 3.246

8.  Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters.

Authors:  Amir Nasrolahi Shirazi; Donghoon Oh; Rakesh Kumar Tiwari; Brian Sullivan; Anju Gupta; Geoffrey D Bothun; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-11-12       Impact factor: 4.939

9.  New core-shell nanoparticules for the intravenous delivery of siRNA to experimental thyroid papillary carcinoma.

Authors:  Henri de Martimprey; Jean-Rémi Bertrand; Claude Malvy; Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2010-01-20       Impact factor: 4.200

Review 10.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.